Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pigmentation Disorder Treatment Market
Pigmentation Disorder Treatment Market size was valued at USD 7.1 billion in 2023 and is expected to reach USD 11.6 billion by 2032, growing at a CAGR of 5.8% over the analysis period. The increasing prevalence of pigmentation disorder, such as vitiligo, melasma, post-inflammatory hyperpigmentation, coupled with growing awareness among the population is driving the market expansion.
For instance, according to a research article published in the Karger Journal in 2021, individuals with dark skin exhibit a notably high prevalence of pigmentary disorders. The pigmentary disorders rank as the 3rd and 4th most common dermatoses worldwide. Therefore, the high prevalence of pigmentation disorders is anticipated to generate opportunities for market expansion globally.
Pigmentation disorder treatment encompasses a range of medical interventions and procedures designed to address and rectify irregularities in skin pigmentation. These conditions result in alterations of skin, hair, or eye coloration due to changes in the production or distribution of melanin, a pigment responsible for determining skin color. The disorders may include vitiligo, melasma, post-inflammatory hyperpigmentation, albinism, and similar conditions.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Pigmentation Disorder Treatment Market Size in 2023: | USD 7.1 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 5.8% |
2024 – 2032 Value Projection: | USD 11.6 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 125 |
Tables, Charts & Figures: | 192 |
Segments covered: | Treatment Type, Type of Disorder, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|